Download Unicorn Signals App

Powered By EquityPandit
Latest News

Sun Pharma has got the approval for acne drug from USFDA

On Wednesday, the drug maker Sun Pharmaceutical Industries said that it has got the US health regulator’s approval for its new drug application for treatment of acne medicine-Ximino TM extended- release capsules.

Sun Pharma said in a statement, The US Food and Drug Administration (USFDA) has approved the company’s supplemental New Drug Application (sNDA) for XiminoTM (Minocycline HCl) extended-release capsules in strengths of 45 mg, 90 mg and 135 mg.

“This approval further strengthens the company’s branded dermatology portfolio in the US. It expects XiminoTM extended-release capsules to be available for patients during the fourth quarter of 2015.”

Read other important stock market news

Get Daily Prediction & Stocks Tips On Your Mobile